Cord blood infusion now available for long COVID patients under expanded access
Disease control
AVAILABLE
This expanded access program offers REGENECYTE, a human umbilical cord blood infusion, to adults with Long COVID who cannot join other clinical trials. Participants must have a recent negative COVID-19 test and provide consent. The goal is to provide potential treatment access wh…
Sponsor: StemCyte, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC